Stimcell Energetics Inc. Files 8-K with Corporate Updates

TL;DR

Stimcell Energetics filed an 8-K on Nov 5th for events on Nov 1st, including corporate changes and financials.

AI Summary

Stimcell Energetics Inc. filed an 8-K on November 5, 2024, reporting events as of November 1, 2024. The filing indicates amendments to its Articles of Incorporation or Bylaws, other events, and financial statements/exhibits. The company, formerly known as Cell MedX Corp., Sports Asylum, Inc., and Plandel Resources, Inc., is incorporated in Nevada with its fiscal year ending May 31.

Why It Matters

This 8-K filing signals potential changes in Stimcell Energetics Inc.'s corporate structure or governance, which could impact its operational direction and investor relations.

Risk Assessment

Risk Level: low — The filing is a routine 8-K reporting corporate events and does not appear to contain significant negative news.

Key Numbers

• 000-54500 — SEC File Number (Identifies the company's filing history with the SEC.)
• 38-3939625 — IRS Number (Company's Employer Identification Number.)

Key Players & Entities

• Stimcell Energetics Inc. (company) — Registrant
• November 1, 2024 (date) — Date of earliest event reported
• November 5, 2024 (date) — Date of report
• Cell MedX Corp. (company) — Former company name
• Sports Asylum, Inc. (company) — Former company name
• Plandel Resources, Inc. (company) — Former company name
• NV (jurisdiction) — State of incorporation

FAQ

Key Financial Figures

• $0 — ,000,000 shares common stock, par value $0.001, of which 297,236,373 shares of com
• $0.001 — ,000 shares of common stock, par value, $0.001 and corresponding decrease in the issue

Filing Documents

• cmxc-20241101.htm (8-K) — 24KB
• cmxc_ex31.htm (EX-3.1) — 1KB
• cmxc_ex32.htm (EX-3.2) — 2KB
• cmxc_ex991.htm (EX-99.1) — 10KB
• cmxcex31_1.jpg (GRAPHIC) — 223KB
• cmxcex32_1.jpg (GRAPHIC) — 229KB
• cmxcex32_2.jpg (GRAPHIC) — 163KB
• cmxcex32_3.jpg (GRAPHIC) — 28KB
• cmxcex32_4.jpg (GRAPHIC) — 157KB
• cmxcex991_1.jpg (GRAPHIC) — 79KB
• 0001393905-24-000378.txt ( ) — 1357KB
• cmxc-20241101_def.xml (EX-101.DEF) — 2KB
• cmxc-20241101_lab.xml (EX-101.LAB) — 13KB
• cmxc-20241101_pre.xml (EX-101.PRE) — 8KB
• cmxc-20241101.xsd (EX-101.SCH) — 2KB
• cmxc-20241101_htm.xml (XML) — 3KB

03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR

ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR. 1:15 Reverse Stock Split Effective November 1, 2024, Cell MedX Corp. (the "Company") completed a 1-for-15 reverse split (the "Reverse Split") of its common stock. As a result of the Reverse Split, the Company's authorized capital was decreased from 7,500,000,000 shares common stock, par value $0.001, of which 297,236,373 shares of common stock were outstanding immediately prior to the Reverse Split, to 500,000,000 shares of common stock, par value $0.001, of which approximately 19,815,758 are outstanding, subject to adjustment for fractional interests resulting from the Reverse Split. Name Change to "Stimcell Energetics Inc." Concurrent with the Reverse Split, the Company amended its articles of incorporation to change the Company's name from "Cell MedX Corp." to "Stimcell Energetics Inc." (the "Name Change")

01 OTHER EVENTS

ITEM 8.01 OTHER EVENTS. In connection with the Reverse Split and the Name Change, effective November 5, 2024, the Company's common stock will trade with a "D" appended to its symbol for a period of 20 business days.

01 FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits The following exhibits are provided with this Current Report: Exhibit Number Description of Exhibit 3.1 Certificate of Change - Decrease in Authorized Capital from 7,500,000,000 shares of common stock, par value $0.001, to 500,000,000 shares of common stock, par value, $0.001 and corresponding decrease in the issued shares of common stock 3.2 Certificate of Amendment - Change of Name to "Stimcell Energetics Inc." and Restatement of Articles of Incorporation 99.1 News release dated November 4, 2024 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STIMCELL ENERGETICS INC. Date: November 4, 2024 By: /s/ David Jeffs David Jeffs, Chief Executive Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR